Showing results (1111-1120 of 1,193) with videos related to
Sort By:
Pageof 120
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Myelodysplastic syndromes, version 2.2015Peter L Greenberg, Richard M Stone, Rafael Bejar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2025
Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AMLCourtney D DiNardo, Jennifer Marvin-Peek, Sanam Loghavi, et al.Nature Communications|November 20, 2020
Publisher Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomicsKiyomi Morita, Feng Wang, Katharina Jahn, et al.Kidney International Supplements|March 10, 2020
Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the worldBarnaby Hole, Brenda Hemmelgarn, Edwina Brown, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2026
The All-Oral Combination of Revumenib, Decitabine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia (SAVE)Ghayas C Issa, Branko Cuglievan, Georgina El Hajjar, et al.Leukemia|December 3, 2025
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective studyCarmelo Gurnari, Hideki Makishima, Arda Durmaz, et al.Renal Failure|December 13, 2006
End-stage renal disease and its treatment in Latin America in the twenty-first centuryAna Cusumano, Guillermo Garcia-Garcia, Cristina Di Gioia, et al.The Lancet. Haematology|June 27, 2020
Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trialElias Jabbour, Guillaume Richard-Carpentier, Yuya Sasaki, et al.American Journal of Hematology|December 2, 2020
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortalityAbhishek Maiti, Wei Qiao, Koji Sasaki, et al.Kidney International|March 25, 2019
Increasing access to integrated ESKD care as part of universal health coverageDavid C H Harris, Simon J Davies, Fredric O Finkelstein, et al.Pageof 120